Seeds of the common bean (Pbaseolus vulgaris) contain a plant defense protein that inhibits the a-amylases of mammals and insects. This a-amylase inhibitor (aAl) is synthesized as a proprotein on the endoplasmic reticulum and is proteolytically processed after arrival in the protein storage vacuoles to polypeptides of relative molecular weight (M,) 15,000 to 18,000. We report two types of evidence that proteolytic processing is linked to activation of the inhibitory activity. First, by surveying seed extracts of wild accessions of P. vulgaris and other species in the genus Pbaseolus, we found that antibodies to uAl recognize large (M. 30,000-35,000) polypeptides as well as typical aAl processing products (M, 15,000-18,000). aAl activity was found in all extracts that had the typical aAl processed polypeptides, but was absent from seed extracts that lacked such polypeptides. Second, we made a mutant aAl in which asparagine-77 is changed to aspartic acid-77. This mutation slows down the proteolytic processing of pro-aAl when the gene is expressed in tobacco. When pro-aAl was separated from mature aAl by gel filtration, pro-aAl was found not to have a-amylase inhibitory activity. We interpret these results to mean that formation of the active inhibitor is causally related to proteolytic processing of the proprotein. We suggest that the polypeptide cleavage removes a conformational constraint on the precursor to produce the biochemically active molecule.
lacked such polypeptides. Second, we made a mutant aAl in which asparagine-77 is changed to aspartic acid-77. This mutation slows down the proteolytic processing of pro-aAl when the gene is expressed in tobacco. When pro-aAl was separated from mature aAl by gel filtration, pro-aAl was found not to have a-amylase inhibitory activity. We interpret these results to mean that formation of the active inhibitor is causally related to proteolytic processing of the proprotein. We suggest that the polypeptide cleavage removes a conformational constraint on the precursor to produce the biochemically active molecule.
Many secretory proteins in plant, mammalian, and funga1 cells are synthesized as preproproteins that undergo cotranslational removal of the signal peptide, as well as posttranslational proteolytic maturation processing (Neurath, 1986) . Such maturation processing, which may occur as a singlestep or a multistep process, converts an inactive proprotein into an active mature protein through the release of a confonnational constraint within the proprotein. Examples are the release of peptide hormones and growth factors in mammalian and yeast cells, the activation of enzyme zymogens, especially proteases, the complement system, and blood coagulation. Processing is often accompanied by the loss of one or more polypeptide domains that are present in the proprotein but absent from the mature protein. Limited proteolysis requires that enzyme and substrate be present in the same compartment and that the processing enzyme be specific for the cleavage and selective for the substrate. 
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Spain-Fulbright Program. Many proteins that accumulate in the protein storage vacuoles of seeds are proteolytically processed there. For example, 60-kD legumin polypeptides are transported as trimers and cleaved into acidic and basic subunits after they amve in the vacuoles (Chrispeels et al., 1982) ; this cleavage is a prerequisite for the final assembly into hexamers (Dickinson et al., 1989) . In this case, the conformational change allows the trimers to assemble into hexamers.
The barley vacuolar glycoprotein aleurain (Holwerda et al., 1990 ) and the soybean vacuolar protein P34 (Kalinski et al., 1992) are putative thiol proteases because of their sequence identity with the cathepsins. They are synthesized as proproteins of 42 to 46 kD and processed to mature proteins of 32 to 34 kD. In analogy with other proteases, this maturation process is thought to convert an inactive proenzyme into an active enzyme, possibly as a result of a conformational change (for review, see Bond and Butler, 1987, and Erickson, 1989) . Plant protease inhibitors, which are usually also vacuolar proteins, do not undergo proteolytic maturation. Tomato protease inhibitor I, which loses a short amino-terminal domain, is an exception (Graham et al., 1985) . Whether this proce sing is related to its activity is not known.
aAI s a vacuolar protein that belongs to a family of seed that includes the lectin PHA (PHA-E and PHA-L) and the various electrophoretic forms of arcelin (see Chrispeels and Raikhel, 1991, for review) . Each of these proteins is synthesized on the ER as a preprotein with M, 25,000 to 28,000 and, after removal of the signal peptide and glycosylation at two or more sites, gives rise to glycoprotein with M, 32,000 to 36,000 that is transported to the protein storage vacuoles. This transport is mediated by the Golgi apparatus where some of the N-linked glycans are modified. aA1 differs uniquely from arcelin and PHA in that it is synthesized as a proprotein that undergoes proteolytic maturation. Amval of aAI in the protein storage vacuoles is followed by two processing events: removal of a short carboxy terminus and proteolytic cleavage at the carboxyl side of Asn77 (Santino et al., 1992) , resulting in the fonnation of a and / 3 subunits with estimated mo1 wt values of 10,000 and 14,600, respectively (Moreno and Chrispeels, 1989; Yamaguchi, 1991) . A comparison of the amino acid sequences of aAI, arcelin, and PHA shows that the Asn processing site of aAI is also present in arcelin but not in PHA. aAI has been purified and partially characterized from different varieties of the common bean, including the white protei I s present in the common bean (Phaseolus vulgaris)
Abbreviations: aAI, a-amylase inhibitor; PHA, phytohemagglutinin. kidney bean (Marshall and Lauda, 1975; Pick and Wober, 1978) , the red kidney bean Whitaker, 1977a, 1977b; Wilcox and Whitaker, 1984a, 1984b) , and the black kidney bean (Lajolo and Finardi Filho, 1985) . The inhibitor blocks the function of mammalian salivary and'pancreatic amylases but not plant, fungal, or bacterial a-amylases. aAIs from red kidney bean and black kidney bean inhibit the aamylase of Tenebrio molitor (Powers and Whitaker, 197713; Frels and Rupnow, 1984) . Furthermore, aAI from kidney bean inhibits a-amylase from three species of bruchids that are seed storage pests (Ishimoto and Kitamura, 1989) .
Because aAI inhibits the development of bruchid beetles (Huesing et al., 1991) , we consider the gene that encodes aAI as potentially useful for crop protection via plant genetic engineering. Before we can proceed with experiments in which the gene for aAI is expressed in heterologous plants, we need to have a more detailed understanding of the role of proteolytic processing of pro-aAI in generating a biologically active molecule. 1s pro-aAI active as an inhibitor or is proteolytic processing required for activity?
We screened seed extracts of other species in the genus Phaseolus as well as wild accessions of P. vulgaris for immunological cross-reactivity with aAI and also for a-amylase inhibitory activity, and found that the presence of a-amylase inhibitory activity was always correlated with the presence of proteolytically processed polypeptides. Then, with sitedirected mutagenesis we changed A d 7 , the residue at the cleavage site of aAI, to AS^^^. Expression of the mutant gene in tobacco resulted in the accumulation of active aAI (processed) and inactive proprotein. Together, these results support the conclusion that proteolytic processing of the proprotein of aAI is linked to the activation of its inhibitory activity.
MATERIALS AND METHODS

Bacterial Strains
The helper strain Escherichia coli HB101, harboring pRK2013, and the Agrobacterium tumefaciens strain LBA4404 were originally obtained from Dr. M. Bevan (Institute for Plant Science Research, Norwick, England). The E. coli DH5a was provided by BRL.
Mutagenesis and Plasmid Construction
The coding sequence for aAI was excised with PstI from the plasmid pPVL134 (Hoffman et al., 1982) and inserted into the PstI site of pMac5-8 vector (Stanssens et al., 1989) . Oligonucleotide-directed mutagenesis was carried out by the gapped duplex DNA method using the pMa/c plasmid vectors (Stanssens et al., 1989) . The ATT codon corresponding to Asn7? was mutated to GAT, which specifies an Asp residue. A HindIII fragment excised from the insert of the pTV562 plasmid (Voelker et al., 1987) containing the dlec2 gene that encodes PHA-L was inserted into the HindIII site of the pUC8 vector and cloned in E. coli DH5a. DNA of this plasmid and the pPVL134 plasmid (or the pMc5-8 vector) that contains the coding sequence of aAI (or mutated aAI) was digested with BsmI and PstI, and the fragments of 3240 bp (pUC8 plus a 536-bp 5' upstream fragment for the PHA-L) and 892 bp (containing the coding sequence) were purified by agarose gel electrophoresis and ligated. The resulting plasmid, the pUC8 vector with a 5.3-kb insert, containing the coding sequence for aA1, a 536-bp PHA-L 5' upstream fragment, and the 3' flanking sequence for the PHA-L, was used to transform E. coli DH5a. This chimeric gene was transferred to the plant vector Binl9 (Bevan, 1984) as a HindIII fragment and maintained in E. coli DH5a.
Transformation of Tobacco
The Binl9 construct was mobilized from E. coli DH5a to A. tumefaciens LBA4404 by triparentral mating with E. coli HBlOl containing pRK2013 (Bevan, 1984 and used to transform leaf discs of Nicotiana tabacum (cv Xanthi). Transformants were selected by their resistance to kanamycin, and transformed plants were regenerated from shootlets by transfer to a root-inducing, kanamycin-containing agar medium as described in Voelker et al. (1987) . The kanamycin-resistant plants were transferred to soil and grown in the greenhouse.
Protein Extraction
Proteins were extracted from tobacco seeds by grinding in an ice-cold mortar with a buffer containing 10 mM Tris (pH 7.9, 0.5 M NaCl, 0.1% Triton X-100, 1% 0-mercaptoethanol, 1 mM PMSF, 0.5 mM pepstatin, 2 pg/mL of leupeptin, and 2 pg/mL of aprotinin (125 mg of seeds per mL of buffer). The extract was centrifuged at 15,OOOg for 10 min and the pellet was discarded. Protein concentration was determined by the Lowry method (Lowry et al., 1951 ) using BSA as a standard.
Electrophoresis and lmmunoblotting
SDS-PAGE (15% acrylamide) was performed according to Laemmli (1970) . After transfer to a nitrocellulose membrane, proteins were detected using a rabbit anti-aAI serum obtained as described (Moreno and Chrispeels, 1989) . We used goat anti-rabbit immunoglobulin G coupled to horseradish peroxidase (Bio-Rad) as a secondary antibody.
(YAI Purification
Porcine pancreas a-amylase (Boehringer Mannheim) was coupled to CNBr-activated Sepharose 48 (Pharmacia) according to the manufacturer's instructions. The beads with immobilized enzyme were equilibrated with 15 mM succinate, 20 mM CaC12, 0.5 M NaCl (pH 5.6), and the inhibitor extract was added (0.2 mL of extract per mL of beads). The mixture was tumbled at 37OC for 1 h, and then the beads were washed with buffer. The inhibitor was released by tumbling for 30 min with 0.12 M sodium citrate (pH 3.0), then the suspension was centrifuged (1500g for 5 min), and the supernatant was brought to pH 5.6 with NaOH and concentrated by centrifugation in a Centricon 10 microconcentrator (Amicon). Molecular size separation was performed with a Sephacryl S-100 (Pharmacia) column (110 X 2 cm) equilibrated in 10 mM Tris (pH 7.5), 6 M urea, and 0.3% pmercaptoethanol. Fractions of 1.5 mL were collected and dialyzed individually against 15 mM succinate buffer (pH 6.9) containing 20 mM CaCL and 0.5 M Natl.
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a-Amylase and Inhibitory Activity
Porcine pancreas a-amylase was from Boehringer Mannheim. T. molitor a-amylase was a crude extract prepared by homogenization of liquid nitrogen-frozen larvae with buffer (15 mM succinate, 20 ITIM CaCk, 0.5 M NaCl, pH 5.6), followed by centrifugation at 10,000g for 30 min at 4°C. For measurements of amylase activity, the method of Bernfeld (1955) was adapted. Appropriate amounts of enzyme were incubated with 1 mL of a 1 % solution of soluble starch prepared in 40 mM potassium phosphate, 50 mM NaCl, pH 6.9. The reaction was stopped by adding 1 mL of dinitrosalicylic acid reagent (Bernfeld, 1955) . The tubes were heated for 10 min in a boiling water bath. Water (8 mL) was added and the A S30 read against a blank prepared in the same manner but without enzyme. A standard curve was prepared using maltose. One enzyme unit is defined as the amount of enzyme that liberates 1 junol of maltose in 1 min at 20°C.
Amylase inhibition was determined by preincubating the enzyme with the aAI extract for 60 min at 37°C in 15 HIM succinate (pH 5.6), 20 mM CaCl 2 , 0.5 M NaCl, and 2 mg/mL of BSA prior to assay of the hydrolytic activity. The results were compared with the activity of the same amount of enzyme without inhibitor. One inhibitory unit was defined as the amount of aAI that completely inhibits one enzyme unit.
(lanes 5). These small aAI-related polypeptides did not react with PHA antibodies. Four seed extracts contained large mol wt polypeptides (M, 32,000-55,000) that reacted with the aAI antibodies (Fig. 1A) . These may represent arcelin (lanes 2 and 3) or other unprocessed molecules in this protein family (lanes 6 and 9) present in other bean species. Immunological cross-reactivity between arcelin and PHA was also observed by Osborn et al. (1988) . Reactivity with PHA antibodies (Fig.  IB) showed that all seeds examined, except those of P. filiformis and P. maculatus, have PHA-related proteins.
These seed extracts were also tested for aAI activity with porcine a-amylase and T. molitor a-amylase as test enzymes. Four seed extracts inhibited T. molitor a-amylase and three of these also inhibited pancreatic a-amylase (Table I ). The four species that had aAI activity also contained the aAI cross-reacting polypeptides, as illustrated in Figure 1 . Together, these results indicate that bean seeds contain a variety of polypeptides that cross-react with aAI and PHA antibodies, but aAI activity is always associated with cross-reacting polypeptides in the M r 14,000 to 18,000 range. The aAI proteins have been purified from three different P. vulgaris cultivars, and in each case the inhibitor consisted of a proteolytically processed polypeptide (Moreno and Chrispeels, 1989; Yamaguchi, 1991) .
Bean aAI Extracts
Phaseolus vulgaris red kidney bean seeds were obtained from the local supermarket. P. vulgaris CIAT G12949 seeds were a gift of Dr. T.C. Osborn (University of Wisconsin, Madison, WI). P. vulgaris CIAT G11051 seeds were donated by Dr. R. Bollini (Instituto Biosintesi Vegetali, Milan, Italy). P. coccineus, P. acutifolius, P. acutifolius tenuifolius, P. filiformis, P. lunatus, and P. maculatus were obtained from Native Seeds/Search (Tucson, AZ).
Seeds were allowed to imbibe in water overnight and proteins were extracted by grinding in an ice-cold mortar in 10 mM (3-mercaptoethanol, 0.5 M NaCl (75 mg of seeds per mL of buffer). The extract was centrifuged at 15,000g for 10 min and the pellet was discarded.
RESULTS
To study the relationship between the activity of aAI in seed extracts and the presence of polypeptides that crossreact with our aAI antiserum, we examined seed extracts from several species in the genus Phaseolus and wild accessions of P. vulgaris that contain arcelin. The seed extracts were separated by SDS-PAGE and immunoblotted with antibodies to PHA and aAI. The specificity of these two antisera is shown in Figure 1 , lanes 1, with proteins from P. vulgaris cv Red Kidney. The aAI antibodies react with aAI (small polypeptides of M r 14,000-18,000) but not with PHA, and the PHA antibodies react with PHA (M r 32,000-36,000) but not with aAI. Besides P. vulgaris cv Red Kidney, three other seed extracts contained small polypeptides in the same M r range that reacted with the aAI antibodies: P. vulgaris CIAT G12949 (lanes 2), P. coccineus (lanes 4), and P. acutifolius 
Tobacco Seeds
Small amounts of unprocessed aAI proprotein en route to the protein storage vacuoles are normally found in the secretory system (ER and Golgi) of developing bean cotyledons. To determine if pro-aAI has a-amylase inhibitory activity, we wished to obtain larger amounts and carried out sitedirected mutagenesis of the gene that encodes aAI to produce a slowly processed or unprocessed proprotein. Amino acid residue Asn 77 , the processing site of aAI, was changed to Asp 77 , and the mutant gene, as well as the wild-type gene, were expressed in tobacco plants with the seed-specific PHA-L promoter. Our previous work had shown that when the gene that encodes aAI is expressed in tobacco seeds with this promoter, active aAI protein is produced (Altabella and Chrispeels, 1990) .
We first checked the abundance of aAI-cross-reacting material in a number of transformed tobacco lines, and selected two-one wild-type and one mutant line-that gave good aAI expression. The accumulation of aAI-cross-reacting polypeptides in mature tobacco seeds of these two lines is shown in Figure 2 . aAI polypeptides in the M r 14,000 to 18,000 range accumulated in both types of seeds. In plants transformed with the wild-type aAI gene, there was no evidence for the existence of the full-length proprotein (M r 32,000) (Fig. 2, lane 3) , presumably because all the proprotein had been processed to mature aAI; however, a considerable amount of proprotein was present in the seeds expressing the mutant aAI gene (Fig. 2, lane 4) . The polypeptides of the processed mutant aAI have somewhat different mobilities than those of wild-type aAI, indicating that a different processing site may have been used. Nearby Asn residues, Asn 69 and Asn 65 , could be processing sites for the Asn-specific enzyme. Alternatively, the enzyme may be utilizing the mutated site (Asp 77 ) and this processing could be followed by the removal of additional amino acids by vacuolar carboxypeptidase to yield a somewhat different polypeptide pattern. An immunoblot of proteins extracted from untransformed tobacco seeds or from seeds transformed only with the Bin 19 vector showed that there are no endogenous tobacco seed proteins that cross-react with our aAI antiserum (Fig. 2) . This indicates that the proprotein immunologically recognized in extracts of seeds containing the mutant gene is indeed a product of that gene.
Wild-Type and Mutant Processed aAI Can Be Purified by Affinity Adsorption
Bean a-amylase inhibitor binds to pancreas a-amylase, forming a stable 1:1 complex (Powers and Whitaker, 1977a) , and small amounts of the protein can be purified on an aamylase Sepharose affinity column (Moreno and Chrispeels, 1989) . aAI was purified from protein extracts of mature tobacco seeds expressing either wild-type or mutant aAI by affinity batch adsorption using porcine pancreas a-amylase coupled to agarose beads. The nonbound and bound fractions were analyzed by immunoblotting (Fig. 3) . The small polypeptides of both wild-type and mutant aAI bound to the a-
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I !« amylase column and could be eluted at low pH (Fig. 3 , lanes 3 and 6). The unprocessed mutant proprotein also bound to the a-amylase affinity column, but the results were variable.
In some experiments, very little proprotein bound to the affinity column, whereas in other experiments as much as half of the proprotein bound to the a-amylase column. Bean pro-aAI obtained from an ER-rich microsomal fraction from mid-mature bean seeds also did not bind to porcine pancreas a-amylase coupled to agarose (Moreno and Chrispeels, 1989) . These results indicate that the proprotein may not be an active inhibitor, or may at best be a weak inhibitor, whereas the processed protein, which binds firmly to the column, is probably the active protein.
Unprocessed aAI Has No Inhibitory Activity
Protein extracts from transgenic tobacco seeds expressing wild-type or mutant aAI and collected at different stages of development were tested for inhibition of porcine pancreas a-amylase. The results shown in Figure 4A indicate an increase in «AI activity associated with seed development. aAI activity was present in both tobacco lines, although the line transformed with wild-type aAI contained nearly 10 times as much activity as the line transformed with mutant aAI. Unfortunately, we were unable to find two transgenic tobacco lines that expressed wild-type and mutant aAI at the same level, as judged by immunoblotting or activity measurements. The differences between the two lines shown in Figure 4A could be the result of differences in the level of gene expression (position effects of the promoter), lower stability of the processed aAI in the tobacco protein storage vacuoles, or an intrinsic lower specific activity of aAI caused by the mutation. Alternate processing may have resulted in a less active protein.
To partially clarify this point, we measured the a-amylase inhibitory activity of affinity-purified wild-type aAI and mutant aAI (Fig. 3, lanes 3 and 6) . Tobacco seed extracts were passed over an a-amylase column, the bound proteins eluted at pH 3.0, and the specific activity of the eluted proteins determined. This allowed us to compare the specific activity of wild-type aAI and mutant aAI both expressed from transgenes in tobacco. The specific activity of the affinity-purified mutant protein (a mixture of processed and unprocessed polypeptides) was about 75% of that of the wild-type aAI (Fig. 4B ). This result indicates that the large differences in aamylase inhibitory activity in the seed extracts shown in Figure 4A were caused mostly by a lower accumulation of the mutant protein and not by the inability of the mutant inhibitor to inhibit a-amylase. Our finding that affinitypurified mutant aAI is 75% as active as wild-type aAI may indicate that alternate processing gives a somewhat less active protein; the nonbound fractions (Fig. 3, lanes 2 and 5) showed no aAI activity.
To determine if the proprotein of aAI has inhibitory activity, the polypeptides present in an extract of mature transgenic tobacco seeds expressing mutant aAI were fractionated on a Sephacryl S-100 column using 6 M urea and 0.3% 0-mercaptoethanol to break the interactions between the subunits. Fractions were collected and analyzed by SDS-PAGE followed by immunoblotting (Fig. 5A) . Fractions 60 to 68 contained the precursor relatively free of processed polypep- tides, which eluted in fractions 68 to 78. Each fraction was dialyzed to eliminate the urea, and the aAI activity of each fraction was tested (Fig. 58) . Fractions containing the high mo1 wt precursor showed no aAI activity, and aAI activity increased with increasing amounts of the processed protein.
These results indicate that aAI in its unprocessed form is inactive and that it has to be proteolytically processed into its subunits to be able to inhibit a-amylase activity. This interpretation agrees with the finding that the specific activity of the affinity-purified mutant protein is smaller than that of the wild-type aAI, because some precursor protein binds to a-amylase but does not inhibit its activity. There is also the possibility that some of the low mo1 wt polypeptides have no activity or a diminished activity. Cleavage of both the mutant and the wild-type aAI results in active protein, but pro-aAI has no activity.
DISCUSSION aAl Activity Requires Proteolytic Processing
In this paper, we provide evidence that processing of the proprotein of aAI is a necessary step in its maturation to become an active inhibitor. The evidence is based on a correlation between aAI activity in seed extracts and the presence of processed aAI polypeptides and on the measurements of inhibitory activity associated with the processing products and the unprocessed precursor. It could be argued, of course, that the mutation we introduced AS^^^ + Asp) caused the mutant proprotein to be inactive, and that wildtype pro-aAI is active. This seems unlikely because proprotein of wild-type aAI does not bind to the a-amylase affinity column and is also probably inactive (see Moreno et al., 1990 ).
Our interpretation is based on the assumption that the M, 32,000 polypeptide that cross-reacts with antibodies to aAI and is present in tobacco seeds of plants transformed with the mutant aAI gene is indeed the biosynthetic precursor of mature aAI. Evidence obtained in our lab (Moreno and Chrispeels, 1989; Moreno et al., 1990 ) and by Santino et al. (1992) supports that assumption. This evidence shows that the initial translation product of the aAI mRNA is about M, 28,000. After remova1 of the signal peptide and the attachment of four glycans, this gives rise to a glycoprotein of 32,000 D. Using pulse-chase experiments, Santino et al. (1992) showed that processing of this proprotein takes place after the inactive inhibitor reaches the protein storage vacuoles. The amino-terminal amino acid sequences of the processing products match the amino terminus of the aAI proprotein and an interna1 sequence starting at amino acid 78.
We do not know whether the mutant polypeptide is processed at the correct site S AS^^^) or at adjacent sites, such as Asd5 or Asd9. The latter seems likely, given the different polypeptide pattem of the processed mutant protein. Our transgenic tobacco plants generally had lower levels of mutant aAI in their seeds compared with wild-type aAI, and this may well be caused by breakdown of aAI resulting from the aberrant processing. However, even if aberrant processing occurs, the specific activity of the processed protein appears to be quite similar to that of correctly processed wild-type aAI.
The survey of seed extracts revealed severa1 interesting findings in addition to the correlation between aAI activity and processed aAI polypeptides. The antibodies to aAI and PHA do not cross-react, but both probably react with the same polypeptides in the wild P. vulgaris accessions (beans containing arcelin) and other Phaseolus species. Evolutionarily, arcelin may well have a position that is intermediate between PHA and aAI. The short deletion of 7 amino acids near the middle of the polypeptide is common to both arcelin and aAI, but the larger deletion of 15 amino acids is found only in aAI (sequence comparisons are shown in Chrispeels and Raikhel, 1991) . A unique feature of the two wild accessions of P. vulgaris is that they are resistant to attack by Zabrotes subfasciatus, a major pest of stored beans (Minney et al., 1990) . This resistance has been associated with the presence of arcelin (Osborn et al., 1988) and has been ascribed to a combination of different factors including the arce1in:phaseolin ratio and a-amylase inhibition (Minney et al., 1990) . P. vulgaris CIAT G12949 and P. vulgaris CIAT G11051 are accessions that, respectively, contain arcelin 4 and arcelin 2. Accession G12949 is believed to inhibit aamylase from Z. subfaciatus, whereas accession G11051 does not inhibit it (Minney et al., 1990) . This is now correlated with the presence in the case of G12949 of small polypeptides that are immunoreactive with aAI antibodies and are absent from G11051. The nature of these polypeptides, which could be a processed arcelin or a distinct aAI protein, remains to be investigated. Another interesting finding is that P. acutifolius extracts showed activity only against insect a-amylase.
This fact may make this aAI more interesting, for it would not be expected to affect starch digestion in mammals as does P. vulgaris aAI (Layer et al., 1985) . The gene encoding aAI from P. acutifolius may therefore be more suitable for crop protection purposes than the homologous gene from
P. vulgaris.
Proteolytic Processing by Specific Proteases Leads to
Activation via the Release of Conformational Constraints
Proteolytic maturation has been studied in many types of proteins including peptide hormones, enzyme zymogens, blood coagulation proteins, and the complement system. Maturation is usually carried out by specific proteases. Proteolysis between two basic residues is involved in the formation of mature a-factor by the Kex2 protease of yeast (Julius et al., 1984) and the maturation of mammalian peptide hormones and neurotransmitters (Docherty and Steiner, 1982) . Where protease activation has been studied, it also has been found to be catalyzed by specific proteases. For example, in yeast, proteinase A processes and activates the vacuolar enzymes carboxypeptidase Y, proteinase B, and aminopeptidase I (see Klionsky et al., 1990, for review) .
In plants, many vacuolar proteins are processed on the carboxyl side of Asn, although other sites have also been identified. aAI, certain vicilins, most legumins, and certain lectins (Con A, pea lectin) are a11 processed at Asn, and an Asn-specific protease has been identified in pumpkin cotyledons (Hara-Nishimura et al., 1991) and in soybean seeds (Scott et al., 1992) . This protease probably processes aAI in bean seeds. Amino acid sequence comparisons among aAI, PHA, and arcelin show that these proteins are homologous, but aAI is unique in that it is the only one of the three that undergoes proteolytic maturation. When aAI is compared with PHA, aAI has two deletions of 15 and 17 amino acids near the middle of the polypeptide. One of these deletions includes the conserved Asn residue that in Con A has been shown to be essential for sugar binding and lectin activity. Therefore, aAI is highly unlikely to be a lectin, and the seeds of the common bean contain only two lectin polypeptides, PHA-E and PHA-L. Unlike aAI, the PHA and arcelin polypeptides are not synthesized as proproteins or proteolytically processed, although arcelin contains Asn in the same position as aAI, and PHA-E and PHA-L contain Asn at nearby positions (two residues upstream). We suggest that the nearby deletions in the aAI polypeptides alter this domain in such a way that it becomes susceptible to proteolytic cleavage.
Con A, the seed lectin homolog from jack bean (Canavalin ensiformis), undergoes proteolytic processing followed by religation of the polypeptides, resulting in a circularly permuted polypeptide (Bowles et al., 1986) . Pro-Con A is not active as a lectin, and activation requires removal of a glycan from a polypeptide loop at the surface of the protein molecule (Sheldon and Bowles, 1992). It is interesting that the remova1 of this glycan and the subsequent cleavage at Asn of pro-Con A occur in a peptide domain that is located in the same position on the protein as the Asn processing site of aAI.
In both these molecules, aAI and Con A, proteolytic processing may result in the release of a conformational constraint that leads to an active molecule. In the case of the aAI proprotein, maturation should create a n active site that allows the molecule to bind to aAI. At the moment, we can only speculate regarding the nature of the active site. In the bacterial a-AI tendamistat, the active site consists of the tripeptide Trp-Arg-Tyr (Kline et al., 1986) . In aA1, a similar active site may be created out of TrpIa8, Arg74, and TyrI9'. Although these residues are located in two different polypeptide domains, they are likely to be located close together in the three-dimensional structure of aAI. We base this prediction on the assumption that the structure of aAI is likely to be similar to that of the legume lectins with which aAI shares considerable amino acid sequence identity (see Sharon and Lis, 1990, and Raikhel, 1991) . The proteolytic cleavage at Asn77 could bring Arg74 into even closer juxtaposition with and TyrI9' to create a n active site similar to that of tendamistat. 
